Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-May 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 145761000001114 | Benefiber powder (GlaxoSmithKline Consumer Healthcare UK Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 145771000001116 | Benefiber powder (GlaxoSmithKline Consumer Healthcare UK Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 2885091000001118 | Benefiber powder (Haleon UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 2885101000001112 | Benefiber powder (Haleon UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 107004601000001112 | Benefiber powder (GlaxoSmithKline Consumer Healthcare) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| 107004701000001119 | Benefiber powder (GlaxoSmithKline Consumer Healthcare) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Benefiber powder (Haleon UK Ltd) 155 gram | Has AMP | True | Benefiber powder (Haleon UK Ltd) | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets